Patents by Inventor Marc Maria Pierre Vandermeeren

Marc Maria Pierre Vandermeeren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
    Patent number: 9939452
    Abstract: This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta_11 N-terminal site, i.e. A?11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: April 10, 2018
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Marc Hubert Mercken, Marc Maria Pierre Vandermeeren
  • N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES
    Publication number: 20170192016
    Abstract: This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta_11 N-terminal site, i.e. A?11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
    Type: Application
    Filed: April 29, 2016
    Publication date: July 6, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Marc Hubert Mercken, Marc Maria Pierre Vandermeeren
  • N-11 truncated amyloid-beta A?11-x monoclonal antibodies and compositions
    Patent number: 9329189
    Abstract: This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta 11 N-terminal site, i.e. A?11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: May 3, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marc Hubert Mercken, Marc Maria Pierre Vandermeeren